Apogee Therapeutics Inc Sustainability Reports
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company that develops differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease, and related inflammatory and immune disorders.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
FIGI: BBG01H51WZL7
1 reports from 2023 to 2023
